 Traditional inflammation and pain relief drugs target both cyclooxygenase 1 and 2, COX-1 and COX-2, causing severe side effects. Here, the authors use in situ-click chemistry to develop COX-2 specific inhibitors with high in vivo anti-inflammatory activity. This article was authored by a tool board watch, Jet Indicor, Melinda Weast, and others.